Portfolio Construction
Discover how HM1 blends high-conviction ideas from top fund managers with annual conference picks—driving returns and funding Australian medical research.

Hearts and Minds is an ASX-listed concentrated global equities firm backed philanthropically by fund managers, directors and service providers' expertise.
heartsandmindsinvestments.com.auCrawled Nov 18, 2026
Discover how HM1 blends high-conviction ideas from top fund managers with annual conference picks—driving returns and funding Australian medical research.
Diversified global income fund providing access to leading international credit managers. 1% all-in fee supporting Australian medical research.
The Hearts & Minds Australian Equities Growth Fund provides investors with access to a diversified portfolio of leading Australian equity fund managers while helping generate funding for important causes in the community.
South Australian medical research will receive a $1.4 million cash injection, as a direct result of a major investment and philanthropy conference held in Adelaide.
The new year offers plenty of potholes for investors, so these 10 fund managers are looking long term. With valuations stretched and geopolitical tensions high, the new year offers plenty of potholes for investors.
The 2025 Sohn Hearts & Minds conference featured global fund managers presenting their top stock ideas.
Where investment meets purpose. Hear from the minds behind breakthroughs in medical research and discover the power of investing for lasting impact.
The HM1 network shares investment news, medical research impact, and insights from its fund managers.
Hearts and Minds Investments (HM1) provides monthly updates on performance, portfolio commentary, dividends, and medical research funding.
Hearts and Minds Investments lists on ASX after strong support for $500m IPO Media Release: HM1 starts trading on the ASX after closing its $500 million IPO early and bringing forward the company's listing date.
Charlie Lanchester joins Hearts and Minds Investments as Chief Investment Officer, bringing experience from BlackRock and Perpetual.
The ongoing support of our board, committees and key service providers is critical to achieving HM1’s philanthropic purpose, enabling us to maximise our impact.
Explore the brilliant minds shaping the HM1 portfolio. Meet our Core and Conference Fund Managers and discover the high-conviction ideas they bring to the table.
Hearts and Minds Investments offers a high-conviction global equities portfolio and supports Australian medical research.
Discover the story behind HM1.ASX – from a bold idea inspired by the Sohn Conference to Australia’s premier investor event and listed investment company driving returns and impact.
Hearts & Minds donates 1.5% of its NTA each year to leading Australian medical research institutes - supporting life-saving breakthroughs and cutting-edge innovation.
Meet the medical research institutes we support. From cancer and cardiovascular health to genomics and neurology, our beneficiaries are tackling the world’s most pressing health challenges.
Suite 12.04a, Level 12, Chifley Tower 2 Chifley Square Sydney, NSW 2000
The page answers common questions about Hearts and Minds Investments, its portfolio, strategy, and medical research commitment.
Listed on the ASX (HM1), Hearts & Minds delivers strong returns via a high-conviction global equities portfolio—while funding Australian medical research.
Hearts and Minds Investments reveals the nine stocks chosen for its 2026/2027 Sohn Conference Portfolio. The selection follows the Sohn Hearts & Minds Investment Leaders Conference, held in Queenstown, New Zealand. The portfolio represents the firm’s curated stock picks for the upcoming period.
HM1 presents its **2026/2027 Conference Portfolio**, featuring nine stocks selected for the **6 November 2026 Sohn Hearts & Minds Investment Leaders Conference** in Queenstown, New Zealand. These holdings account for roughly **35% of HM1’s total investments** and are typically retained for **12 months**. The portfolio highlights HM1’s strategic focus on curated, short-term stock selections tied to its annual conference.
Hearts and Minds Investments (ASX:HM1) declares a **10.0-cent fully franked final FY26 dividend per share** while disclosing a **2.0% portfolio decline in September 2026**. The update reflects the firm’s global investment strategy and recent market performance.
Cuffe’s Third Link is merging with Hearts & Minds. The deal combines two funds management firms, though specific terms or strategic details remain undisclosed. Both entities operate within Australia’s investment management sector.
Hearts & Minds Investments is assuming management of the Third Link Growth Fund following their announced merger. The deal consolidates investment operations under Hearts & Minds while retaining the fund’s existing structure. No further details on terms or strategic rationale have been disclosed.
Hearts and Minds Investments reports stable Net Tangible Asset (NTA) values for the week ending 3 July 2026, despite ongoing market volatility. The firm holds its unlisted software stock, Rokt, at the same valuation as December 2025, maintaining portfolio consistency. This stability supports investor confidence amid fluctuations in the broader software sector.
The Sohn Hearts and Minds Conference, marking its 10th anniversary, presents nine new investment ideas to attendees. The event blends finance, health, business, innovation, research, and politics, featuring a high-energy closing performance by Hoodoo Gurus members. Past conference selections delivered a 38% return, suggesting potential high-value insights for investors.
Hearts & Minds’ board demands guarantees from a New York-based hedge fund to prevent the dissolution of its $700 million ASX-listed charity investment fund. The fund has reportedly threatened to push for the vehicle’s winding up, raising concerns among directors. The board now seeks written assurances to protect the fund’s operations and assets.
Hearts & Minds Investments, a $650 million fund linked to a charity stock-picking initiative, shifts from public equities to private investments. The fund acquires stakes in **Rokt**, a commerce-enabling platform, and **Guzman y Gomez**, a specialty coffee retailer. This marks its first direct investment in unlisted companies.